2018 3 21 Naltrexone Not a Primary Medication Assisted Treatment – But Still Worth Knowing 20180321
Автор: FADAA Webinars
Загружено: 2025-12-17
Просмотров: 5
Описание:
Naltrexone: Not a Primary MAT - but Still Worth Knowing
Presented by: David R. Gastfriend, MD, DFASAM
Event Date: 03-21-2018
Event Description: Oral naltrexone (NTX-PO) is a potent blocker at brain opioid receptors, so it was a natural consideration as a medication in addiction treatment (MAT) for Opioid Use Disorder (OUD). For most OUD patients, however, studies have not found NTX-PO to be any better than placebo or non-medication treatment – due to poor adherence by patients. Nevertheless, it is still used for patients whose pill-taking can be regularly monitored, for detoxification and induction onto extended-release naltrexone, and for patients who have completed MAT but encounter new stressors for which they may want temporary protection from relapse.
View Webinar | View Presentation Materials
This training is supported by the Florida Department of Children and Families Office of Substance Abuse and Mental Health.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
